# Steroids vs Placebo in Treatment of Tuberculous Lymphadenitis

> **NCT06236152** · NA · COMPLETED · sponsor: **Fahad Javed Awan** · enrollment: 140 (actual)

## Conditions studied

- Tuberculous Lymphadenitis, Cervical

## Interventions

- **DRUG:** Ferrous sulfate
- **DRUG:** Deltacortril

## Key facts

- **NCT ID:** NCT06236152
- **Lead sponsor:** Fahad Javed Awan
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-01
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-08-15
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2024-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06236152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06236152, "Steroids vs Placebo in Treatment of Tuberculous Lymphadenitis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06236152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*